GLAM
XENT

Gardner Lewis Asset Management’s Intersect ENT, Inc XENT Stock Holding History

Gardner Lewis Asset Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-102,827
Closed -$2.88M – 92
2022
Q1 		$2.88M Buy
+102,827
New +$2.82M 0.51% 53

Gardner Lewis Asset Management's XENT Position: Q2 2022 in Review

Gardner Lewis Asset Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 102,827 shares — an estimated $2.88M sold.

Gardner Lewis Asset Management first reported a position in XENT in Q1 2022 and held it in 1 quarter. The position peaked at $2.88M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Gardner Lewis Asset Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 102,827 Intersect ENT, Inc shares in Q2 2022, an estimated $2.88M.
  • Gardner Lewis Asset Management first reported a position in Intersect ENT, Inc in Q1 2022 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Intersect ENT, Inc position peaked at $2.88M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.